ConductScience.org, home

Paper16916645

UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation.

Machida YJ and 6 others. Mol Cell, 2006. Cited by 238 papers, by iCite.

Cite this record

ConductScience Library. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Papers, record 16916645. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16916645

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation.
PubMed
Journal
Mol Cell
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
238
iCite
Relative citation ratio, by iCite
4.05
iCite
Revised in PubMed
2025-05-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Machida YJYuichi J
2Machida YYuka
3Chen YYuefeng
4Gurtan AMAllan M
5Kupfer GMGary M
6D'Andrea ADAlan D
7Dutta AAnindya

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Fanconi AnemiaMajor topic
HomeostasisMajor topic
Ubiquitin-Conjugating EnzymesMajor topic
Chromosome Aberrations
Fanconi Anemia Complementation Group D2 Protein
Fanconi Anemia Complementation Group L Protein
Humans
Mitomycin
Molecular Sequence Data
Protein Binding
Tumor Cells, Cultured
Ubiquitin

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA060499NCI NIH HHSUnited StatesR01CA060499PubMed and NIHNIH RePORTER
R01 CA60499NCI NIH HHSUnited StatesR01CA060499PubMed and NIHNIH RePORTER
R01 HL063776NHLBI NIH HHSUnited StatesR01HL063776PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by172

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 238 citations.

PMIDTitleJournalYearIn PapersSource
42937821Ubiquitin Chloromethylketone Probe Enables Activity-Based Protein Profiling of E2 Ubiquitin Conjugating Enzymes.J Am Chem Soc2026https://conductscience.org/library/papers/42937821PubMed
42846171Atypical Presentation of UBE2T-Related Fanconi Anemia With Immune-Mediated Thrombocytopenia and Hematopoietic Somatic Mosaicism: A Case Report.EJHaem2026https://conductscience.org/library/papers/42846171PubMed
42292533
Critical Biological Functions and Clinical Implications of Epigenetic-Related Candidate Biomarkers in Chronic Obstructive Pulmonary Disease: Integrated Machine Learning Screening and Basic Experimental Validation.
Int J Chron Obstruct Pulmon Dis2026https://conductscience.org/library/papers/42292533PubMed
42152107DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42152107PubMed
42074182Intron Retention as a Homeostatic State Variable for Drug Response and Recovery: Lessons from Depression for Broader Applications.Int J Mol Sci2026https://conductscience.org/library/papers/42074182PubMed
41751958
FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer.
Int J Mol Sci2026https://conductscience.org/library/papers/41751958PubMed
41673685Identification of UBE2T as a novel diagnostic biomarker of psoriasis and proliferating UBE2T+ Keratinocyte in psoriasis.J Transl Med2026https://conductscience.org/library/papers/41673685PubMed
40710415Computational and Imaging Approaches for Precision Characterization of Bone, Cartilage, and Synovial Biomolecules.J Pers Med2025https://conductscience.org/library/papers/40710415PubMed
40274197USP1 inhibition: A journey from target discovery to clinical translation.Pharmacol Ther2025https://conductscience.org/library/papers/40274197PubMed
40259951Analysis of Ubiquitin-Conjugating Enzyme E2T (UBE2T) Protein Levels in the Bone Marrow Biopsy Specimens of Patients With Multiple Myeloma.Cureus2025https://conductscience.org/library/papers/40259951PubMed
39915000UBE2T/CDC42/CD276 signaling axis mediates brain metastasis of triple-negative breast cancer via lysosomal autophagy.J Immunother Cancer2025https://conductscience.org/library/papers/39915000PubMed
39851497Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities.Cells2025https://conductscience.org/library/papers/39851497PubMed
39791716Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review.Cells2024https://conductscience.org/library/papers/39791716PubMed
39289660UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation.BMC Cancer2024https://conductscience.org/library/papers/39289660PubMed
38846492Research progress on the fanconi anemia signaling pathway in non-obstructive azoospermia.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/38846492PubMed
38626770Global, site-resolved analysis of ubiquitylation occupancy and turnover rate reveals systems properties.Cell2024https://conductscience.org/library/papers/38626770PubMed
38584528Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis.Curr Protein Pept Sci2024https://conductscience.org/library/papers/38584528PubMed
38358126Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screening.Protein Sci2024https://conductscience.org/library/papers/38358126PubMed
38332367Structural mechanisms of autoinhibition and substrate recognition by the ubiquitin ligase HACE1.Nat Struct Mol Biol2024https://conductscience.org/library/papers/38332367PubMed
37923882DNA Damage Responses, the Trump Card of Stem Cells in the Survival Game.Adv Exp Med Biol2024https://conductscience.org/library/papers/37923882PubMed

See all 172 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FANCD22177Swiss-Prot's referenceshttps://conductscience.org/library/genes/2177NCBI Gene
FANCL55120Swiss-Prot's referenceshttps://conductscience.org/library/genes/55120NCBI Gene
UBE2T29089Swiss-Prot's referenceshttps://conductscience.org/library/genes/29089NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
RefSeqNM_014176

Source RefSeq

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16916645

GET https://conductscience.org/api/papers/v1/16916645/cited_by?page=2